Valuation: Embracing Future Holdings Limited

Market Cap 71.07M 55.07M 48.14M 44.52M 40.85M 77.32M 5.31B 78.66M 531M 209M 2.59B 207M 202M 8.95B P/E 2024
-8.18x
P/E 2025 -22.5x
Enterprise Value 72.93M 56.51M 49.4M 45.68M 41.92M 79.34M 5.45B 80.71M 545M 214M 2.66B 212M 208M 9.18B EV / Sales 2024
58.8x
EV / Sales 2025 17.5x
Free-Float
44.94%
Yield 2024 *
-
Yield 2025 -
1 day-2.38%
1 week-4.65%
Current month-4.65%
1 month-16.33%
3 months-30.51%
6 months-46.75%
Current year-21.15%
1 week 0.04
Extreme 0.038
0.04
1 month 0.04
Extreme 0.038
0.05
Current year 0.04
Extreme 0.038
0.09
1 year 0.02
Extreme 0.021
0.09
3 years 0.01
Extreme 0.008
0.09
5 years 0.01
Extreme 0.008
0.28
10 years 0.01
Extreme 0.008
0.88
Manager TitleAgeSince
President 46 2024-04-29
Comptroller/Controller/Auditor 44 2024-06-30
Corporate Secretary - -
Director TitleAgeSince
Director/Board Member 55 2023-03-30
Director/Board Member 70 2023-11-26
Director/Board Member 64 2021-06-13
Date Insider Type Main position Quantity % Market Cap.
4/30/21 Fiscal year

Chairman

330,000 0.1250%
8/19/20 Free

Chairman

1,130,000 0.4340%
Change 5-day change 1-year change 3-year change Capi.($)
-2.38%-4.65%+86.36%+156.25% 55.11M
+0.33%+2.27%+28.90%+2.16% 199B
+0.96%+3.39%+4.82%-14.78% 142B
+2.30%-3.14%-22.24%+12.66% 138B
+3.81%-0.50%-56.62%-14.91% 63.97B
-0.33%-4.70%+14.32%-6.06% 50.25B
+1.18%+2.27%-23.75%-31.73% 44.33B
-0.28%+0.48%+18.34%+13.52% 38.05B
+0.46%-0.30%+29.85%+39.34% 36.81B
+2.07%-0.31%-14.51%-20.56% 28.75B
Average +0.78%-0.91%+6.55%+13.59% 74.1B
Weighted average by Cap. +1.15%+0.18%+1.08%-1.63%

Financials

2024 2025
Net sales 858K 665K 581K 537K 493K 933K 64.06M 950K 6.41M 2.52M 31.28M 2.5M 2.44M 108M 5.26M 4.08M 3.56M 3.3M 3.02M 5.72M 393M 5.82M 39.3M 15.44M 192M 15.31M 14.97M 662M
Net income -3.43M -2.66M -2.33M -2.15M -1.97M -3.74M -256M -3.8M -25.65M -10.08M -125M -9.99M -9.77M -432M -3.96M -3.07M -2.68M -2.48M -2.28M -4.31M -296M -4.39M -29.6M -11.63M -144M -11.53M -11.28M -499M
Net Debt 1.46M 1.13M 986K 911K 836K 1.58M 109M 1.61M 10.87M 4.27M 53.05M 4.23M 4.14M 183M 1.86M 1.44M 1.26M 1.16M 1.07M 2.02M 139M 2.05M 13.86M 5.45M 67.67M 5.4M 5.28M 234M
Logo Embracing Future Holdings Limited
Biolidics Limited is a Singapore-based precision medicine medical technology company. The Company's principal activities are technology development, technology transfer, selling and distribution of biomedical technology, life and medicine science related products and services; provision of laboratory services and investment holding. Its segments are Cancer, Infectious diseases, and Laboratory services, and Corporate segments. Its Cancer and infectious diseases segments involve the identifying and assessing potential collaboration partners, technology, products and services, product development, innovation and improvement and the management of global distributorship networks and direct customers in the cancer field, and the infectious diseases field. The Laboratory services segment involves the business, operation, and provision of laboratory services to customers. The laboratory has regulatory approval from Singapore’s Ministry of Health for testing for COVID-19 in Singapore.
Employees
16
Date Price Change Volume
26-07-14 SGD 0.0410 -2.38% 200
26-07-13 SGD 0.0420 0.00% 415,500
26-07-10 SGD 0.0420 -2.33% 305,300